Impaired corneal wound healing associated with ketorolac 0.5% after uncomplicated extracapsular cataract extraction

Cornea

Volumn 26, Issue 10, 2007, Pages 1159-1164

  Arey, Mark L ^a   Sullivan, Brian R ^a,b   Reinert, Carol G ^b   McCulley, James P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Cataract surgery; Ketorolac; NSAID; Wound healing

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CIPROFLOXACIN; GENTAMICIN; KETOROLAC TROMETAMOL; MAXITROL; METHYLPREDNISOLONE; MURO 128; POLYSPORIN; PREDNISOLONE ACETATE; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CATARACT; CLINICAL ARTICLE; CORNEA INJURY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOPHTHALMITIS; EXTRACAPSULAR CATARACT EXTRACTION; HUMAN; LENS IMPLANTATION; MALE; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE; WOUND DEHISCENCE; WOUND HEALING IMPAIRMENT;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATARACT EXTRACTION; CORNEA; HUMANS; KETOROLAC; LENS IMPLANTATION, INTRAOCULAR; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURGICAL WOUND DEHISCENCE; WOUND HEALING;

EID: 36549025525     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31814b1b19     Document Type: Article

References (9)

1. Rho DS. Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg. 2003;29:2378-2384.
2. Weisz JM, Bressler NM, Bressler SB, et al. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction. Ophthalmology. 1999;106:1656-1659.
3. Congdon NG, Schein OD, von Kulajta P, et al. Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs. J Cataract Refract Surg. 2001;27:622-631.
4. Reviglio VE, Rana TS, Li QJ, et al. Effects of topical nonsteroidal antiinflammatory drugs on the expression of matrix metalloproteinases in the cornea. J Cataract Refract Surg. 2003;29:989-997.
5. O'Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin. 2005;21:1131-1137.
6. Dirks MS. Safety of topical NSAIDs. Ocular Surgery News. U.S. Edition Monograph, February 15, 2006.
7. O'Brien TP, Li QJ, Sauerburger F, et al. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use. Ophthalmology. 2001;108:656-659.
8. Hargrave SL, Jung JC, Fini ME, et al. Possible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal melting: an analysis of postoperative keratolysis. Ophthalmology. 2002;109:343-350.
9. Nwomeh BC, Liang HX, Cohen IK, et al. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res. 1999;81:189-195.